LY5625575
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 10, 2026
A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)
(clinicaltrials.gov)
- P1 | N=204 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Inflammation
September 04, 2026
A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)
(clinicaltrials.gov)
- P1 | N=204 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Inflammation
1 to 2
Of
2
Go to page
1